Jove
Visualize
联系我们
这页已由机器翻译。其他页面可能仍然显示为英文。View in English
  1. 首页
  3. 研究领域
  5. 生物医学和临床科学
  7. 瘤学和致癌症
  9. 预测和预后标志物
  11. 与肺癌患者抗瘤疗法相关的肺栓塞时间模式和危险因素
  1. 首页
  3. 研究领域
  5. 生物医学和临床科学
  7. 瘤学和致癌症
  9. 预测和预后标志物
  11. 与肺癌患者抗瘤疗法相关的肺栓塞时间模式和危险因素

相关实验视频

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.6K

与肺癌患者抗瘤疗法相关的肺栓塞时间模式和危险因素

Yi-Wen Zhang1, Dong-Chun Ma2, Rui Tao1

  • 1Department of Respiratory Medicine, Anhui Medical University Clinical College of Chest &Anhui Chest Hospital, Hefei, 230022, People's Republic of China.

Annals of vascular surgery
|September 5, 2025

在PubMed 上查看摘要

概括
此摘要是机器生成的。

肺癌患者的肺栓塞 (PE) 风险随着治疗而变化. 外科手术增加了PE风险,特别是在治疗的早期,强调需要监测和个性化抗凝策略.

科学领域:

  • 癌症学
  • 心脏病学
  • 肺部医学

背景情况:

  • 肺癌患者面临肺栓塞的风险增加.
  • 特定抗瘤疗法与肺癌PE发病之间的关联需要进一步描述.
  • 识别高风险人群对于及时干预至关重要.

研究的目的:

  • 研究各种抗瘤疗法与肺栓塞 (PE) 发病时间之间的关系.
  • 在癌症治疗期间确定患PE风险较高的患者子组.
  • 为肺癌PE的临床监测和管理策略提供信息.

主要方法:

  • 在抗瘤治疗期间发生PE的106名肺癌患者的回顾性分析 (2019-2025年).
  • 数据收集包括人口统计,癌症阶段,治疗类型和PE发病时间.
  • 经过螺旋CT或肺血管扫描证实PE诊断.

主要成果:

  • 在50.95%的病例中,PE发生在诊断后的六个月内.
  • 与联合治疗 (15. 52个月) 相比,手术干预是PE的独立风险因素,较早发病 (1. 81个月).
  • 在开始治疗后的三个月内,经过化疗 (46. 15%),向治疗 (34. 78%) 和手术 (77. 78%) 的治疗,发育前期的发病率有所不同.
关键词:
肺癌 肺癌肺栓塞 肺栓塞风险因素治疗方法时间节点

更多相关视频

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

13.8K
Lung Tumor Cell Recruitment Assay
04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

5.5K

相关实验视频

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.6K
Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

13.8K
Lung Tumor Cell Recruitment Assay
04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

5.5K

相关概念视频

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

45
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
45
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

35
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
35
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

42
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
42
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

905
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
905
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

22
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
22
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

结论:

  • 在肺癌中使用的抗瘤治疗类型显著影响了PE的发生率和时间.
  • 在这一群体中,手术是PE发展的关键风险因素.
  • 在整个肺癌治疗过程中,警监测,风险分层和量身定制的抗凝药是必不可少的.